Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mass spectrometry-based draft of the mouse proteome.
Nat Methods. 2022 Jul;19(7):803-811. doi: 10.1038/s41592-022-01526-y. Epub 2022 Jun 16.
Nat Methods. 2022.
PMID: 35710609
Free PMC article.
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype.
Orben F, Lankes K, Schneeweis C, Hassan Z, Jakubowsky H, Krauß L, Boniolo F, Schneider C, Schäfer A, Murr J, Schlag C, Kong B, Öllinger R, Wang C, Beyer G, Mahajan UM, Xue Y, Mayerle J, Schmid RM, Kuster B, Rad R, Braun CJ, Wirth M, Reichert M, Saur D, Schneider G.
Orben F, et al. Among authors: jakubowsky h.
JCI Insight. 2022 May 23;7(10):e151353. doi: 10.1172/jci.insight.151353.
JCI Insight. 2022.
PMID: 35439169
Free PMC article.
Item in Clipboard
Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systems.
Peschke K, Jakubowsky H, Schäfer A, Maurer C, Lange S, Orben F, Bernad R, Harder FN, Eiber M, Öllinger R, Steiger K, Schlitter M, Weichert W, Mayr U, Phillip V, Schlag C, Schmid RM, Braren RF, Kong B, Demir IE, Friess H, Rad R, Saur D, Schneider G, Reichert M.
Peschke K, et al. Among authors: jakubowsky h.
EMBO Mol Med. 2022 Apr 7;14(4):e14876. doi: 10.15252/emmm.202114876. Epub 2022 Feb 4.
EMBO Mol Med. 2022.
PMID: 35119792
Free PMC article.
Item in Clipboard
Cite
Cite